Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

86.60 1.50 −1.70%
Market cap
$50.8B
P/E
49.8×
Fwd P/E
30.7×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a

Edwards Lifesciences Corporation (EW) Book value per share

Alert me on Book value per share

Edwards Lifesciences Corporation's book value per share at the end of fiscal 2025 was 17.7×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 18.6×. Over the past ten years it has ranged from 3.9× (fiscal 2015) to 17.7× (fiscal 2025) — the current reading is the highest in ten years. Edwards Lifesciences Corporation ranks 22nd of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 17.7× 5.00%
FY2024 16.8× 52.01%
FY2023 11.1× 18.06%
FY2022 9.4× 0.19%
FY2021 9.4× 27.44%
FY2020 7.3× 10.66%
FY2019 6.6× 32.69%
FY2018 5.0× 7.09%
FY2017 4.7× 14.00%
FY2016 4.1× 5.86%

Quarterly newest first

Period Book value per share Change
Jun 2026 18.6× 4.35%
Mar 2026 17.8× 0.87%
Dec 2025 17.7× 1.28%
Sep 2025 17.5× (3.41%)
42 more quarters

Against its own ten years

Low 3.9× High 17.7×
Ten-year median 7.3×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on EW